The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis.

Background:Disease-modifying therapies (DMTs) are used to treat people with relapsing-onset multiple sclerosis (ROMS), but our knowledge is largely limited to their short-term effects.Objective:To ...